Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Murielle Roussel, Benjamin Hebraud, Cyrille Hulin, Aurore Perrot, Denis Caillot, Anne-Marie Stoppa, Margaret Macro, Martine Escoffre, Bertrand Arnulf, Karim Belhadj, Lionel Karlin, Laurent Garderet, Thierry Facon, Shien Guo, Josh Weng, Sujith Dhanasiri, Xavier Leleu, Philippe Moreau & Michel Attal. (2020) Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Leukemia & Lymphoma 61:6, pages 1323-1333.
Read now
Read now
Samantha Seitzler, Elizabeth Finley-Oliver, Christine Simonelli & Rachid Baz. (2019) Quality of life in multiple myeloma: considerations and recommendations. Expert Review of Hematology 12:6, pages 419-424.
Read now
Read now
Dan T. Vogl, Michel Delforge, Kevin Song, Shien Guo, Craig J. Gibson, Annette Ervin-Haynes & Thierry Facon. (2018) Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone. Leukemia & Lymphoma 59:2, pages 398-405.
Read now
Read now
Nadine Kutsch, Raymonde Busch, Jasmin Bahlo, Jiri Mayer, Manfred Hensel, Georg Hopfinger, Georg Hess, Ulrich von Grünhagen, Clemens-Martin Wendtner, Anna Maria Fink, Kirsten Fischer, Michael Hallek & Barbara Eichhorst. (2017) FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 58:2, pages 399-407.
Read now
Read now
Emmanuelle Le Ray, Sundar Jagannath & Antonio Palumbo. (2016) Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma. Expert Review of Hematology 9:1, pages 91-105.
Read now
Read now
Articles from other publishers (24)
Rafael Fonseca, Diana Tran, Alyshia Laidlaw, Emily Rosta, Manvir Rai, Joana Duran & Eric M. Ammann. (2023) Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review. Clinical Lymphoma Myeloma and Leukemia 23:6, pages 426-437.e11.
Crossref
Crossref
Ademola S. Ojo, Oluwasegun Akinyemi, Mojisola O. Araoye & Ahmed Ali. (2022) Early Intervention With a Curative Intent Through an Intensive Therapy Versus Immunologic Disease Control Using a Minimal Intensity Approach in the Management of High-risk Smoldering Multiple Myeloma: A Systematic Review of Evidence From Clinical Trials. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
Fabio Efficace, Francesco Cottone, Francesco Sparano, Giovanni Caocci, Marco Vignetti & Rajshekhar Chakraborty. (2022) Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021. Clinical Lymphoma Myeloma and Leukemia 22:7, pages 442-459.
Crossref
Crossref
Gil Hevroni & Neha Korde. (2022) Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives. Seminars in Oncology 49:1, pages 94-102.
Crossref
Crossref
Stefan Knop, Maria-Victoria Mateos, Meletios A. Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Ganna Usenko, Ludek Pour, Mark Cook, Sebastian Grosicki, Andre Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Losava, Tomoaki Fujisaki, Mamta Garg, Jianping Wang, Susan Wroblewski, Anupa Kudva, Katharine S. Gries, John Fastenau, Jesus San-Miguel & Michele Cavo. (2021) Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial. BMC Cancer 21:1.
Crossref
Crossref
Torben Plesner, Meletios A. Dimopoulos, Albert Oriol, Jesus San‐Miguel, Nizar J. Bahlis, Neil Rabin, Kenshi Suzuki, Sung‐Soo Yoon, Dina Ben‐Yehuda, Gordon Cook, Hartmut Goldschmidt, Sebastian Grosicki, Xiang Qin, John Fastenau, Wendy Garvin, Robin Carson, Thomas Renaud & Katharine S. Gries. (2021) Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial. British Journal of Haematology 194:1, pages 132-139.
Crossref
Crossref
Vania Hungria, Meral Beksac, Katja C. Weisel, Ajay K. Nooka, Tamas Masszi, Ivan Spicka, Markus Munder, María‐Victoria Mateos, Tomer M. Mark, Ming Qi, Xiang Qin, John Fastenau, Andrew Spencer, Pieter Sonneveld, Wendy Garvin, Thomas Renaud & Katharine S. Gries. (2021) Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial. British Journal of Haematology 193:3, pages 561-569.
Crossref
Crossref
Aurore Perrot, Thierry Facon, Torben Plesner, Saad Z. Usmani, Shaji Kumar, Nizar J. Bahlis, Cyrille Hulin, Robert Z. Orlowski, Hareth Nahi, Peter Mollee, Karthik Ramasamy, Murielle Roussel, Arnaud Jaccard, Michel Delforge, Lionel Karlin, Bertrand Arnulf, Ajai Chari, Jianming He, Kai Fai Ho, Rian Van Rampelbergh, Clarissa M. Uhlar, Jianping Wang, Rachel Kobos, Katharine S. Gries, John Fastenau & Katja Weisel. (2021) Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial. Journal of Clinical Oncology 39:3, pages 227-237.
Crossref
Crossref
Rajshekhar Chakraborty, Laura Cannella, Francesco Cottone & Fabio Efficace. (2020) Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review. The Lancet Haematology 7:12, pages e892-e901.
Crossref
Crossref
Hira Mian, Gregory R. Pond, Sascha A. Tuchman, Mark A. Fiala & Tanya M. Wildes. (2020) Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment. Journal of Geriatric Oncology 11:8, pages 1279-1284.
Crossref
Crossref
Xiaozhe Li, Junru Liu, Meilan Chen, Jingli Gu, Beihui Huang, Dong Zheng & Juan Li. (2020) Health‐related quality of life of patients with multiple myeloma: A real‐world study in China. Cancer Medicine 9:21, pages 7896-7913.
Crossref
Crossref
N.V. Skvortsova, I.B. Kovynyov, K.V. Khalzov, I.N. Nechunaeva & T.I. Pospelova. (2020) Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice. Clinical oncohematology 13:3, pages 322-334.
Crossref
Crossref
Vanessa Piechotta, Tina Jakob, Peter Langer, Ina Monsef, Christof Scheid, Lise J Estcourt, Sunday Ocheni, Sebastian Theurich, Kathrin Kuhr, Benjamin Scheckel, Anne Adams & Nicole Skoetz. (2019) Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Crossref
Joseph Mikhael, Nofisat Ismaila, Matthew C. Cheung, Caitlin Costello, Madhav V. Dhodapkar, Shaji Kumar, Martha Lacy, Brea Lipe, Richard F. Little, Anna Nikonova, James Omel, Namrata Peswani, Anca Prica, Noopur Raje, Rahul Seth, David H. Vesole, Irwin Walker, Alexander Whitley, Tanya M. Wildes, Sandy W. Wong & Tom Martin. (2019) Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline. Journal of Clinical Oncology 37:14, pages 1228-1263.
Crossref
Crossref
Lene Kongsgaard Nielsen, Niels Abildgaard, Mary Jarden & Tobias Wirenfeld Klausen. (2019) Methodological aspects of health‐related quality of life measurement and analysis in patients with multiple myeloma. British Journal of Haematology 185:1, pages 11-24.
Crossref
Crossref
Kara-Louise Royle, Walter M. Gregory, David A. Cairns, Sue E. Bell, Gordon Cook, Roger G. Owen, Mark T. Drayson, Faith E. Davies, Graham H. Jackson, Gareth J. Morgan & J. Anthony Child. (2018) Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study. British Journal of Haematology 182:6, pages 816-829.
Crossref
Crossref
Tracy A. King, Madeline T. King & Kate J. White. (2017) Patient Reported Outcomes in Optimizing Myeloma Patients' Health-Related Quality of Life. Seminars in Oncology Nursing 33:3, pages 299-315.
Crossref
Crossref
Cyrille Hulin, Timon Hansen, Louise Heron, Rachel Pughe, Matthew Streetly, Ananda Plate, Sue Perkins, Kate Morgan, Antoine Tinel, Filipe Rodrigues & Karthik Ramasamy. (2017) Living with the burden of relapse in multiple myeloma from the patient and physician perspective. Leukemia Research 59, pages 75-84.
Crossref
Crossref
Tanya M. Wildes & Erica Campagnaro. (2017) Management of multiple myeloma in older adults: Gaining ground with geriatric assessment. Journal of Geriatric Oncology 8:1, pages 1-7.
Crossref
Crossref
Christina Ramsenthaler, Thomas R. Osborne, Wei Gao, Richard J. Siegert, Polly M. Edmonds, Stephen A. Schey & Irene J. Higginson. (2016) The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16:1.
Crossref
Crossref
Christina Ramsenthaler, Pauline Kane, Wei Gao, Richard J. Siegert, Polly M. Edmonds, Stephen A. Schey & Irene J. Higginson. (2016) Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. European Journal of Haematology 97:5, pages 416-429.
Crossref
Crossref
Don RobinsonJrJr, Dixie‐Lee Esseltine, Antoine Regnault, Juliette Meunier, Kevin Liu & Helgi Velde. (2016) The influence of baseline characteristics and disease stage on health‐related quality of life in multiple myeloma: findings from six randomized controlled trials. British Journal of Haematology 174:3, pages 368-381.
Crossref
Crossref
Hemant S. Murthy & William A. Wood. (2015) The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology. Current Hematologic Malignancy Reports 10:3, pages 213-224.
Crossref
Crossref
M. W. M. van der Poel, S. Oerlemans, H. C. Schouten & L. V. van de Poll-Franse. (2014) Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Annals of Hematology 94:4, pages 651-661.
Crossref
Crossref